| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/10/1994 | EP0609961A1 Sustained release pharmaceutical composition |
| 08/10/1994 | EP0609345A1 Biocompatible implant for the timing of ovulation in mares |
| 08/10/1994 | EP0609336A1 Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered |
| 08/10/1994 | EP0609330A1 Composition for topical application |
| 08/10/1994 | EP0609221A1 Antimicrobial dialdehyde composition and methods of use. |
| 08/10/1994 | EP0533739B1 Injectable pharmaceutical composition |
| 08/10/1994 | EP0302065B1 Pharmaceutical compositions |
| 08/10/1994 | CN1090509A Pharmaceutical composition |
| 08/10/1994 | CN1090508A Physiologically active peptide composition |
| 08/10/1994 | CN1090507A Anti-myopia increasing sight paste and scream and its preparing method |
| 08/10/1994 | CN1090506A External application Chinese tradilional drug for anti-AIDS |
| 08/10/1994 | CN1090504A Pertiuacious illness clearing agent for external application |
| 08/10/1994 | CN1090494A Bear bile powder enteric capsule and preparing technology |
| 08/10/1994 | CN1090488A Delivery device having encapsulated excipients |
| 08/10/1994 | CN1090487A Forsythia fruit coptis chinensis aerosol, spray and enema and its preparing method |
| 08/10/1994 | CN1025591C Method for production of vaginal suppositories |
| 08/10/1994 | CN1025586C Cassette system and apparatus for manufacturing an active agent liberating capsule for subcutanoues use |
| 08/09/1994 | USRE34692 Active substance deopt, active substance delivery control means and pressure sensitive adhesive |
| 08/09/1994 | US5336767 Total or partial esters of hyaluronic acid |
| 08/09/1994 | US5336669 Mixture with hydrate which has been melted, precipitated, refrozen and redried, crystal structure, water solubility |
| 08/09/1994 | US5336668 Esters of alginic acid |
| 08/09/1994 | US5336508 Sodium silver chloride |
| 08/09/1994 | US5336507 Use of charged phospholipids to reduce nanoparticle aggregation |
| 08/09/1994 | US5336505 Bioerodible polymers useful for the controlled release of therapeutic agents |
| 08/09/1994 | US5336504 Sustained release drug delivery by administering pellets with core of diltiazem and organic acid mixture surrounded by multilayered membrane containing blends of both water soluble and insoluble synthetic polymers |
| 08/09/1994 | US5336501 Cross-linked hydrogels and their use as wound dressings |
| 08/09/1994 | US5336499 Molecular crystal device for pharmaceuticals |
| 08/09/1994 | US5336494 Produces antibacterial and bacteriostatic effect in mouth by activation of enzyme system within the coating |
| 08/09/1994 | US5336486 Administering polycarbophil by mouth in amount to suppress appetite without inducing laxative effect |
| 08/09/1994 | US5336484 Compositions of iodophenyl esters and iodophenyl sulfonates in film-forming materials for visualization of the gastronintestinal tract |
| 08/09/1994 | US5336271 Method for increasing the proportion of a crystalline organic compound which remains uncrystallized in a composite particulate product and suppressing recrystallization |
| 08/09/1994 | US5336213 Selectable dosage transdermal delivery system |
| 08/09/1994 | US5336210 Plaster agent |
| 08/09/1994 | US5336175 Method for the treatment of retinal detachments |
| 08/09/1994 | CA1331344C Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates |
| 08/09/1994 | CA1331343C Adjuvant-enhanced sustained released composition and method for making |
| 08/09/1994 | CA1331342C Compressed-molded preparations |
| 08/09/1994 | CA1331341C Covered retard forms |
| 08/09/1994 | CA1331340C Method for preventing the formation of a crystalline hydrate in a dispersion of liquid in a nonaqueous matrix |
| 08/09/1994 | CA1331338C Aqueous film-forming compositions for controlling the release of active agents and process of making same |
| 08/09/1994 | CA1331328C Delivery system comprising means for governing fluid ingress into the system |
| 08/04/1994 | WO1994017538A2 Microparticle switching devices |
| 08/04/1994 | WO1994016756A1 Intrapulmonary delivery of hormones |
| 08/04/1994 | WO1994016739A1 Phase shift colloids as ultrasound contrast agents |
| 08/04/1994 | WO1994016732A1 Ectoparasiticidal formulation |
| 08/04/1994 | WO1994016728A1 Monoclonal anti-lfa-1 antibodies for the preparation of a medicament intended to prevent the rejection of organ transplants |
| 08/04/1994 | WO1994016720A1 COMPOSITIONS CONTAINING TRANSFORMING GROWTH FACTOR β STABILIZED BY GLYCOSAMINOGLYCANS |
| 08/04/1994 | WO1994016717A1 Method of treating diabetes mellitus |
| 08/04/1994 | WO1994016709A2 Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 08/04/1994 | WO1994016708A1 Pharmaceutical composition for treating nicotine dependence |
| 08/04/1994 | WO1994016707A1 Transdermal therapeutic system with galanthamine as active ingredient |
| 08/04/1994 | WO1994016699A1 Compositions containing tandospirone or its analogs |
| 08/04/1994 | WO1994016695A1 Pharmaceutical compositions containing cimetidine |
| 08/04/1994 | WO1994016693A1 Stable oral ci-981 formulation and process of preparing same |
| 08/04/1994 | WO1994016692A1 Method and compositions for treating anoestrus |
| 08/04/1994 | WO1994016691A1 Nitroglycerine-containing plaster, process for producing the same and its use |
| 08/04/1994 | WO1994016688A1 Nutritive composition |
| 08/04/1994 | WO1994016683A1 Magnetically responsive composition for carrying biologically active substances and methods of production and use |
| 08/04/1994 | WO1994016682A1 Novel, percutaneously absorbable preparation |
| 08/04/1994 | WO1994016681A1 Recombinant living subunit vaccine composition and process for its preparation |
| 08/04/1994 | WO1994009785A3 Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis |
| 08/04/1994 | WO1993025583A3 Proteinoid carriers and methods for preparation and use thereof |
| 08/04/1994 | DE4403157A1 Schmerzlindernde Präparate zur topischen Anwendung auf der Haut Analgesic preparations for topical application to the skin |
| 08/04/1994 | CA2154902A1 Recombinant living subunit vaccine composition and process for its preparation |
| 08/04/1994 | CA2154278A1 Anti-lfa-1 monoclonal antibodies used for the preparation of a medecine prenventing the rejection of grafted organs |
| 08/04/1994 | CA2153990A1 Microparticle switching devices |
| 08/04/1994 | CA2153882A1 Novel transdermal absorption preparation |
| 08/04/1994 | CA2153571A1 Nitroglycerine-containing plaster, process for producing the same and its use |
| 08/04/1994 | CA2152673A1 Compositions containing tandospirone or its analogs |
| 08/03/1994 | EP0609042A1 Drug composition and process for preparing the same |
| 08/03/1994 | EP0608850A1 Process for the preparation of microgranules suitable for suspension after coating in pharmaceutical liquid compositions |
| 08/03/1994 | EP0608831A1 Compositions containing argatroban analogs |
| 08/03/1994 | EP0608828A1 Compositions containing argatroban analogs |
| 08/03/1994 | EP0608648A1 High dose vitamin A compositions |
| 08/03/1994 | EP0608600A1 Cosmetic composition |
| 08/03/1994 | EP0608419A1 Transocular preparation |
| 08/03/1994 | EP0608362A1 Device for the transdermal administration of melatonin |
| 08/03/1994 | EP0608357A1 Device for administering drug transdermally with a controlled temporal change in skin flux |
| 08/03/1994 | EP0608353A1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES. |
| 08/03/1994 | EP0608341A1 Enzyme-orthokeratology |
| 08/03/1994 | EP0608322A1 Enhanced skin penetration system for improved topical delivery of drugs |
| 08/03/1994 | EP0608320A1 Enhanced skin penetration system for improved topical delivery of drugs |
| 08/03/1994 | EP0608217A1 Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition |
| 08/03/1994 | EP0402407B1 Transdermal estradiol delivery system |
| 08/03/1994 | EP0269696B1 Transdermal absorption dosage unit for estradiol and other estrogenic steroids |
| 08/03/1994 | CN1090205A Preparation of aquogel with polyvinyl alcohol support and its products |
| 08/03/1994 | CN1090199A Preparation of polyporus umbellatus polysaccharose capsule |
| 08/03/1994 | CN1090195A Medicine for curing comedo |
| 08/03/1994 | CN1090192A Taiqiping paste and its preparation |
| 08/03/1994 | CN1090189A Chinese medicine for constipation and its preparation |
| 08/03/1994 | CN1090175A Fortifier which promotes growth of erythrocytes and prevents from anemia |
| 08/03/1994 | CN1090174A Stabilised hexadecylphosphocholine solutions in glycerol alkyl ethers |
| 08/03/1994 | CN1090172A Method for producing microcapsule |
| 08/03/1994 | CN1090171A Oral medicament form |
| 08/03/1994 | CN1090170A Novel composition based on taxoides derivative |
| 08/03/1994 | CN1090126A Quick-drying gel-type disinfectant for hands and fingers |
| 08/03/1994 | CN1025548C Process for producing miniature capsule |
| 08/02/1994 | USRE34682 Aqueous dispersions of polyester and polyesteramides cross-linked with metallic ions and casts made therefrom |
| 08/02/1994 | US5334761 Cationic lipids |
| 08/02/1994 | US5334640 Ionically covalently crosslinked and crosslinkable biocompatible encapsulation compositions and methods |